Sreekanth Dittakavi

Employment

• LAXAI Life Sciences Pvt Ltd Assistant Director
  2020 - Present
• Jubilant Biosys LTD Sr.Reserach Scientist
  2016 - 2020
• Syngene International Ltd Sr. Associate Scientist
  2013 - 2016
• Aurigene Discovery Technologies LTD Junior Scientist
  2010 - 2013
• Suven Life Sciences Limited Research Associate
  2007 - 2010

Education

• Indian Institute of Management Visakhapatnam Certification course
  2024 - Present
• Shri Jagdishprasad Jhabarmal Tibrewala University Doctor of Philosophy
  2015 - 2020

Projects & Funding

Projects & funding information is unavailable.

Publications (29)

• Preclinical Assessment and Tissue Distribution of Vodobatinib, a Third Generation BCr-Abl 1 Inhibitor
  Drug Research 2026 DOI: 10.1055/a-2877-4153
  +Save
• Validation of a Dried Blood Spot Method for the Determination of a Third‐Generation Bcr‐Abl 1 Inhibitor, Vodobatinib, in Small Volumes of Rat Blood: Application to a Pharmacokinetic Study
  Biomedical Chromatography 2025 DOI: 10.1002/bmc.70204
  +Save
• Validated HPLC‐UV Method for the Quantification of a Novel BCr‐Abl 1 Inhibitor, Vodobatinib, in Rat Plasma: Application to a Pharmacokinetic Study
  Biomedical Chromatography 2025 DOI: 10.1002/bmc.6077
  +Save
• Highly Sensitive LC–MS/MS Method for Determination of Dexamethasone in Rat Plasma and Brain Tissue: An Application to Pharmacokinetic Study in Rats
  Biomedical Chromatography 2025 DOI: 10.1002/bmc.6059
  +Save
• Validated LC–MS/MS method for the determination of copanlisib in mouse dried blood spots
  Biomedical Chromatography 2023 DOI: 10.1002/bmc.5548
  +Save
• Validated HPLC‐UV method for quantification of paxalisib, a pan PI3K and mTOR inhibitor in mouse plasma: Application to a pharmacokinetic study in mice
  Biomedical Chromatography 2023 DOI: 10.1002/bmc.5587
  +Save
• Novel tricyclic small molecule inhibitors of Nicotinamide N-methyltransferase for the treatment of metabolic disorders
  Scientific Reports 2022 DOI: 10.1038/s41598-022-19634-2
  +Save
• Validated liquid chromatography–tandem mass spectrometry method for simultaneous quantitation of bendamustine and copanlisib in mouse plasma: Application to a pharmacokinetic study in mice
  Biomedical Chromatography 2022 DOI: 10.1002/bmc.5387
  +Save
• Validated LC-MS/MS Method for Simultaneous Quantitation of Three PI3K Inhibitors, Copanlisib, Duvelisib and Idelalisib in Mouse Plasma: Application to a Pharmacokinetic Study in Mice
  Analytical Chemistry Letters 2021 DOI: 10.1080/22297928.2021.1895885
  +Save
• Bioanalytical method development and validation for establishing bioavailability and bioequivalence
  Biopharmaceutics and Pharmacokinetics Considerations 2021 DOI: 10.1016/b978-0-12-814425-1.00001-2
  +Save